Events

In partnership with CURE, BVS is excited to host a Biotech Innovation Supplier Expo and Networking Event in New York. Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. This event is focusing on new and emerging technologies that are...

Life Sciences companies often rely on traditional, document-centric methods to capture process specifications. This approach is highly manual, error-prone, and limits reusability, resulting in disconnected systems, inefficient work, and extended calendar time. This webinar will showcase real-world results of transferring process specifications into execution systems at a clinical supply center.

We are very excited to be hosting the BVS & Aquillius' Biotech Community Halloween Party and Vendor Expo. Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. We are inviting the entire San Diego Life Science Community to join us...

For a biotech company, selecting the right bioanalysis CRO partner can make or break their program timeline. Nobody wants to be the next cautionary tale that plagues the industry of continuous delays, miscommunication or hidden fees. Bottom line: the right bioanalysis CRO becomes a true accelerator; the wrong one slows you down. But when everyone...

Join Bill Turner, Technical Service Manager, Tooling and Tablets from Natoli Engineering as he shares insights on the latest innovations and solutions shaping tablet compression efficiency and quality, and Robert Sedlock, Director of Natoli Scientific as he shares his expertise on USP with scale up. This session will provide valuable takeaways for engineers, operators, and...

Bioprocess Online's Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions, attendees will have the chance to explore the newest equipment and solutions offered by our presenters, aimed at addressing the current challenges within the drug development process. This interactive online platform ensures convenience and...

Sterile filtration is a pivotal step in viral vector manufacturing, influencing product quality, yield, and regulatory compliance. This webinar highlights advances in sterile filtration for viral vectors, with a focus on Supor™ EKV and Supor™ Prime filters in adeno-associated virus (AAV) and lentivirus workflows. Real-world case studies will illustrate how optimized filtration and process design...

Bioprocess Online's Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions, attendees will have the chance to explore the newest equipment and solutions offered by our presenters, aimed at addressing the current challenges within the drug development process. This interactive online platform ensures convenience and...

Many Life sciences manufacturers have positioned Pharma 4.0 on the manufacturing floor as a critical strategic initiative, however the existence of legacy systems and fragmented data silos poses a huge challenge. By decoupling control logic from hardware, software-defined manufacturing powered by Honeywell Aptica delivers the flexibility and scalability to adapt rapidly to changing business and...

Outsourcing small molecule drug development and manufacturing remains complex—but staying on track with timelines is still critical. Success depends on seamless technology transfers and robust analytical strategies. In this session, industry experts will share best practices for streamlining processes between sponsors and CDMOs. Attendees will walk away with actionable insights into aligning analytical methods and...

Bioprocess Online's Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions, attendees will have the chance to explore the newest equipment and solutions offered by our presenters, aimed at addressing the current challenges within the drug development process. This interactive online platform ensures convenience and...

BVS in partnership with King Street Properties, Inc. will be hosting this Networking & Innovation Biotech Community Event at The Landing in Burlingame! Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. The Landing is a state of the art...

In this webinar, we will explore how biobased Thermo Scientific™ BioProcess Containers (BPCs) and cell culture systems help enable companies claim measurable reductions in Scope 3 carbon emissions. We will highlight the environmental and operational benefits of adopting biobased single-use systems, including quantifiable reductions in CO₂ emissions equivalent to removing dozens of gas-powered vehicles from...

This webinar will showcase ElevateBio’s expertise through the perspectives of the site head, head of manufacturing, and head of quality, emphasizing their integrated approach. Key discussion points will include how ElevateBio approaches manufacturing from a quality perspective, how they handle segregation and control in a multi-product facility, their ability to meet the demands of commercial-scale...

This interactive roundtable brought together industry experts to explore the unique challenges of outsourcing peptide drug development with CDMOs and CMOs. The conversation highlights critical pain points across the development journey, including: - Synthesis & Scale-Up: The technical complexity of moving from lab-scale peptide synthesis to commercial volumes while managing yield, purity, and cost. -...

The optimization of cell culture media is a critical factor in achieving efficient and reliable vaccine production. Among the key components, peptones have demonstrated significant potential in enhancing cell growth, viability, and productivity. In this webinar, we will explore the impact of peptones on vaccine manufacturing, with a focus on their role in improving performance...

In addition to basic chemicals and formulation, there are other criteria that contribute to making something an effective and optimal sporicide. The requirements for selecting an agent or replacing an existing sporicide for use within the clean room facility should consider several key factors. This webinar, presented by Professor Tim Sandle, PhD in partnership with...

In an era of rapid disruption and technological advancement, clinical operations leaders face mounting pressure to deliver greater effectiveness while navigating complex trade-offs. This webinar explores how organizations are rethinking their clinical operating models—balancing innovation, efficiency, and strategic decision-making. Join industry experts as we unpack the latest trends, challenges, and opportunities shaping the future of...

Biologic therapies are transforming healthcare, but their complexity brings unique challenges for downstream quality control (QC). Ensuring product purity, safety, and consistency requires precise and reliable analytical methods, especially in the face of regulatory scrutiny. Two critical areas of focus are HPLC protein analytics and residual DNA testing, both of which present technical hurdles that...

Biopharmaceutical development requires a clear understanding of how process conditions affect product quality. For therapeutic antibodies, preserving biological activity—such as antigen binding and effector functions—depends on precise control of cell culture environments. Traditional scale-up metrics like power per volume (P/V), however, often fall short when processes are transferred across facilities or equipment scales. In this...

The Regional Biotechnology Conference is an annual conference that attracts more than 100 of the region’s movers and shakers for a half-day of dynamic speakers and topics that are important to start-up and early stage biotech company leaders. This year's conference will feature keynote speakers, Nicholas A. Siciliano, Ph.D., CEO of Vittoria Biotherapeutics. The afternoon...

The minimum-viable-product concept was born not in advanced therapy, but in the tech sector. It asks: What's the smallest set of materials or features required to achieve the desired outcome? This principle can be a powerful guide when sourcing raw materials for gene therapy. Executive Editor Jon O'Connell hosts this Cell & Gene Live event,...

Following the first mRNA-LNP based Covid-19 vaccines, a plethora of new modalities were invented that are directed to treating and preventing diseases in previously unimaginable ways. With these new modalities, both in the field of XNA and their encapsulating modalities (Lipid Nano Particles) standard methods fall short, lacking the resolution, specificity, and adaptability needed to...

A limited proportion of drug candidates ultimately achieve regulatory approval, often due to challenges such as insufficient efficacy, safety concerns, complex or poorly understood targets, limitations in predictive preclinical models, or commercial viability issues. Given the significant cost and time associated with development, early identification of promising candidates and the implementation of a robust development...

Join Stephen Ferrell, Chief Product Officer at Valkit.ai as he provides a critical analysis of one of the most significant regulatory updates to impact pharmaceutical computerized systems in over a decade. The proposed EU GMP Annex 11 revision transforms European compliance requirements from risk-based guidance to prescriptive technical specifications, introducing mandatory audit trails for all...

The oligonucleotide market is moving fast. Now is an exciting time with 20 therapeutics on the market and so many oligos being developed for future treatments. While the market traditionally centred around the outstanding and essential work with rare diseases, some blockbusters are emerging for much larger patient indications. We know that you’re the expert...

As the demand for plasmid DNA (pDNA) continues to surge across gene therapies, mRNA vaccines, and cell therapies, manufacturers are facing growing pressure to expand capacity with speed and precision. But scaling pDNA production is far from straightforward. Unforeseen complexities in areas like facility design or process innovation often leads to costly delays and missed...

We are very excited to announce our indoor Biotech Innovation & Vendor Expo at the Cambridge Marriott. Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. This biotech community event will bring together researchers from local biotech/pharma accounts in Cambridge/Boston...

Selecting the right CRO is one of the most critical decisions in clinical development, yet rarely a straightforward one. Sponsors often find that comparing CRO proposals isn’t an apples-to-apples exercise — with variations in assumptions, timelines, and resource structures making true comparisons difficult. This session draws on insights from more than $2B in CRO selections...

AAV vectors offer clear benefits for gene therapy, and continued advances in technology have increased target specificity, improved potency, and intensified production efficiency. Even with significant attention early in development, analytical activities for gene therapy often land on the critical path. This webinar provides considerations for phase-appropriate AAV characterization and release activities from pre-clinical to...

We are very excited to invite you to our BVS Holiday Biotech Community Event - an evening of celebration, networking, and festive cheer! Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. This special event is designed exclusively for all...